References
- Andersson, M., Groseclose, M.R., Deutch, A.Y., and Caprioli, R.M. (2008). Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat. Methods 5, 101-108. https://doi.org/10.1038/nmeth1145
- Bosso, N., Chinello, C., Picozzi, S.C., Gianazza, E., Mainini, V., Galbusera, C., Raimondo, F., Perego, R., Casellato, S., Rocco, F., et al. (2008). Human urine biomarkers of renal cell carcinoma evaluated by ClinProt. Proteomics Clin. Appl. 2, 1036-1046. https://doi.org/10.1002/prca.200780139
- Chaurand, P., Schwartz, S.A., and Caprioli, R.M. (2002). Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr. Opin. Chem. Biol. 6, 676-681. https://doi.org/10.1016/S1367-5931(02)00370-8
- Chaurand, P., Schwartz, S.A., Reyzer, M.L., and Caprioli, R.M. (2005). Imaging mass spectrometry: principles and potentials. Toxicol. Pathol. 33, 92-101. https://doi.org/10.1080/01926230590881862
- Chaurand, P., Norris, J.L., Cornett, D.S., Mobley, J.A., and Caprioli, R.M. (2006). New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J. Proteome Res. 5, 2889-2900. https://doi.org/10.1021/pr060346u
- Essen, A., Ozen, H., Ayhan, A., Ergen, A., Tasar, C., and Remzi, F. (1991). Serum ferritin: a tumor marker for renal cell carcinoma. J. Urol. 145, 1134-1137. https://doi.org/10.1016/S0022-5347(17)38555-5
- Francese, S., Dani, F.R., Traldi, P., Mastrobuoni, G., Pieraccini, G., and Moneti, G. (2009). MALDI mass spectrometry imaging, from its origins up to today: the state of the art. Comb. Chem. High Throughput Screen 12, 156-174. https://doi.org/10.2174/138620709787315454
- Fuhrman, S.A., Lasky, L.C., and Limas, C. (1982). Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 6, 655-663. https://doi.org/10.1097/00000478-198210000-00007
- Kanamori, T., Takakura, K., Mandai, M., Kariya, M., Fukuhara, K., Sakaguchi, M., Huh, N.H., Saito, K., Sakurai, T., Fujita, J., et al. (2004). Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol. Hum. Reprod.10, 735-742. https://doi.org/10.1093/molehr/gah100
- Keller, A., Nesvizhskii, A.I., Kolker, E., and Aebersold, R. (2002). Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392. https://doi.org/10.1021/ac025747h
- Kirkali, Z., Guzelsoy, M., Mungan, M.U., Kirkali, G., and Yorukoglu, K. (1999). Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume. Urol. Int. 62, 21-25. https://doi.org/10.1159/000030349
- Ljungberg, B. (2004). Prognostic factors in renal cell carcinoma. Scand. J. Surg. 93, 118-125. https://doi.org/10.1177/145749690409300206
- Miyata, Y., Koga, S., Nishikido, M., Hayashi, T., and Kanetake, H. (2001). Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma. BJU Int. 88, 974-977.
- Morgan, T.M., Seeley, E.H., Fadare, O., Caprioli, R.M., and Clark, P.E. (2013). Imaging the clear cell renal cell carcinoma proteome. J. Urol. 189, 1097-1103. https://doi.org/10.1016/j.juro.2012.09.074
- Motzer, R.J., Bander, N.H., and Nanus, D.M. (1996). Renal-cell carcinoma. N Engl. J. Med. 335, 865-875. https://doi.org/10.1056/NEJM199609193351207
- Ohuchida, K., Mizumoto, K., Ohhashi, S., Yamaguchi, H., Konomi, H., Nagai, E., Yamaguchi, K., Tsuneyoshi, M., and Tanaka, M. (2006). S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin. Cancer Res. 12, 5417-5422. https://doi.org/10.1158/1078-0432.CCR-06-0222
- Ozen, H., Uygur, C., Sahin, A., Tekgul, S., Ergen, A., and Remzi, D. (1995). Clinical significance of serum ferritin in patients with renal cell carcinoma. Urology 46, 494-498. https://doi.org/10.1016/S0090-4295(99)80261-1
- Rehman, I., Azzouzi, A.R., Cross, S.S., Deloulme, J.C., Catto, J.W., Wylde, N., Larre, S., Champigneuille, J., and Hamdy, F.C. (2004). Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Hum. Pathol. 35, 1385-1391. https://doi.org/10.1016/j.humpath.2004.07.015
- Rocca, P.C., Brunelli, M., Gobbo, S., Eccher, A., Bragantini, E., Mina, M.M., Ficarra, V., Zattoni, F., Zamo, A., Pea, M., et al. (2007). Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod. Pathol. 20, 722-728. https://doi.org/10.1038/modpathol.3800828
- Seliger, B., Dressler, S.P., Lichtenfels, R., and Kellner, R. (2007). Candidate biomarkers in renal cell carcinoma. Proteomics 7, 4601-4612. https://doi.org/10.1002/pmic.200700415
- Singh, K.J., Singh, S.K., Suri, A., Vijjan, V., Goswami, A.K., and Khullar, M. (2005). Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage. Indian J. Cancer 42, 197-200.
- Siu, K.W., DeSouza, L.V., Scorilas, A., Romaschin, A.D., Honey, R.J., Stewart, R., Pace, K., Youssef, Y., Chow, T.F., and Yousef, G.M. (2009). Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J. Proteome Res. 8, 3797-3807. https://doi.org/10.1021/pr800389e
- Steurer, S., Seddiqi, A.S., Singer, J.M., Bahar, A.S., Eichelberg, C., Rink, M., Dahlem, R., Huland, H., Sauter, G., Simon, R., et al. (2014). MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype. Anticancer Res. 34, 2255-2261.
- Stoeckli, M., Chaurand, P., Hallahan, D.E., and Caprioli, R.M. (2001). Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat. Med. 7, 493-496. https://doi.org/10.1038/86573
- Stulik, J., Koupilova, K., Osterreicher, J., Knizek, J., Macela, A., Bures, J., Jandik, P., Langr, F., Dedic, K., and Jungblut, P.R. (1999). Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 20, 3638-3646. https://doi.org/10.1002/(SICI)1522-2683(19991201)20:18<3638::AID-ELPS3638>3.0.CO;2-W
- Torres-Cabala, C., Panizo-Santos, A., Krutzsch, H.C., Barazi, H., Namba, M., Sakaguchi, M., Roberts, D.D., and Merino, M.J. (2004). Differential expression of S100C in thyroid lesions. Int. J. Surg. Pathol. 12, 107-115. https://doi.org/10.1177/106689690401200203
- Tyszkiewicz, T., Jarzab, M., Szymczyk, C., Kowal, M., Krajewska, J., Jaworska, M., Fraczek, M., Krajewska, A., Hadas, E., Swierniak, M., et al. (2014). Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa. Folia Histochem. Cytobiol. 52, 79-89. https://doi.org/10.5603/FHC.2014.0018
- Unwin, R.D., Craven, R.A., Harnden, P., Hanrahan, S., Totty, N., Knowles, M., Eardley, I., Selby, P.J., and Banks, R.E. (2003). Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 3, 1620-1632. https://doi.org/10.1002/pmic.200300464
- Wang, G., Wang, X., Wang, S., Song, H., Sun, H., Yuan, W., Cao, B., Bai, J., and Fu, S. (2008). Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues. Int. J. Colorectal. Dis. 23, 675-682. https://doi.org/10.1007/s00384-008-0464-6
- Yang, H., Zhao, K., Yu, Q., Wang, X., Song, Y., and Li, R. (2012). Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma. J. Int. Med. Res. 40, 475-485. https://doi.org/10.1177/147323001204000209
Cited by
- Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer vol.153, 2017, https://doi.org/10.1016/j.jprot.2016.11.006
- Clinical applications of MALDI imaging technologies in cancer and neurodegenerative diseases vol.1865, pp.7, 2017, https://doi.org/10.1016/j.bbapap.2017.01.005
- Targeting Cancer Metabolism - Revisiting the Warburg Effects vol.32, pp.3, 2016, https://doi.org/10.5487/TR.2016.32.3.177
- Surface-Transfer Mass Spectrometry Imaging of Renal Tissue on Gold Nanoparticle Enhanced Target vol.88, pp.14, 2016, https://doi.org/10.1021/acs.analchem.6b01859
- Involvement of S6K1 in mitochondria function and structure in HeLa cells vol.28, pp.12, 2016, https://doi.org/10.1016/j.cellsig.2016.09.003
- Mitochondrial transcription factor A (TFAM) is upregulated in glioma vol.15, pp.6, 2017, https://doi.org/10.3892/mmr.2017.6467
- Proteomic profiling of human plasma for cancer biomarker discovery vol.17, pp.6, 2017, https://doi.org/10.1002/pmic.201600240
- MALDI mass spectrometry imaging in rheumatic diseases vol.1865, pp.7, 2017, https://doi.org/10.1016/j.bbapap.2016.10.004
- MALDI mass spectrometry imaging: A cutting-edge tool for fundamental and clinical histopathology vol.10, pp.7, 2016, https://doi.org/10.1002/prca.201500140
- The proteomic landscape of renal tumors vol.13, pp.12, 2016, https://doi.org/10.1080/14789450.2016.1248415
- Label-free molecular imaging of the kidney vol.92, pp.3, 2017, https://doi.org/10.1016/j.kint.2017.03.052
- Deciphering the complexity of the cancer proteome for diagnostic applications vol.16, pp.4, 2016, https://doi.org/10.1586/14737159.2016.1135738
- MALDI imaging mass spectrometry as a novel tool for detecting histone modifications in clinical tissue samples vol.13, pp.3, 2016, https://doi.org/10.1586/14789450.2016.1146598
- Profiling and identification of new proteins involved in brain ischemia using MALDI-imaging-mass-spectrometry vol.152, 2017, https://doi.org/10.1016/j.jprot.2016.11.014
- Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor vol.33, pp.1, 2017, https://doi.org/10.5487/TR.2017.33.1.063
- Laser desorption/ionization MS imaging of cancer kidney tissue on silver nanoparticle-enhanced target vol.10, pp.2, 2018, https://doi.org/10.4155/bio-2017-0195
- MALDI-IMS Assisted by On-Tissue Chemical Derivatization for Visualizing Amino Acid Distribution in a Single Tissue Slice vol.63, pp.6, 2015, https://doi.org/10.5702/massspec.s15-27
- Anti-aging effects of Piper cambodianum P. Fourn. extract on normal human dermal fibroblast cells and a wound-healing model in mice vol.11, pp.None, 2015, https://doi.org/10.2147/cia.s107734
- The roles of TRIO and F-actin-binding protein in glioblastoma cells vol.17, pp.3, 2018, https://doi.org/10.3892/mmr.2018.8458
- MicroLESA: Integrating Autofluorescence Microscopy, In Situ Micro-Digestions, and Liquid Extraction Surface Analysis for High Spatial Resolution Targeted Proteomic Studies vol.91, pp.12, 2019, https://doi.org/10.1021/acs.analchem.8b05889
- Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy vol.11, pp.20, 2020, https://doi.org/10.7150/jca.47698
- Increasing Complexity to Simplify Clinical Care: High Resolution Mass Spectrometry as an Enabler of AI Guided Clinical and Therapeutic Monitoring vol.3, pp.4, 2015, https://doi.org/10.1002/adtp.201900163
- Mass Spectrometric (MS) Analysis of Proteins and Peptides vol.21, pp.None, 2020, https://doi.org/10.2174/1389203721666200726223336
- Imaging the kidney: from light to super-resolution microscopy vol.36, pp.1, 2015, https://doi.org/10.1093/ndt/gfz136
- Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research vol.58, pp.7, 2015, https://doi.org/10.1080/10408363.2021.1942781